Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content and preventing access to the ClinicalTrials.gov record.
    Difference
    0.5%
    Check dated 2026-09-27T19:56:12.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed, indicating access is blocked; the study content and navigation blocks that normally present trial details are replaced by a standard error view.
    Difference
    16%
    Check dated 2026-09-20T20:43:26.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now states the study has 199 locations and removes several previously listed sites. The eligibility language is refined to specify TP53 wild-type status by central NGS for histologically confirmed endometrial cancer.
    Difference
    0.5%
    Check dated 2026-08-30T21:54:41.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page's revision metadata updated from v3.6.4 to v3.6.5, indicating a newer build of the page. No study data or visible content appears to be affected.
    Difference
    0.0%
    Check dated 2026-08-09T11:11:19.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    A new page revision tag indicates the study page was updated from version v3.6.3 to v3.6.4. This appears to be a minor metadata update rather than a substantive change to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T17:16:40.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was recorded in the page history, replacing v3.6.2. This is a minor version update and does not change the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-04T05:18:19.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.